(+)-alpha-tocopherol multiple interactions ISO RGD:735787 6480464 alpha-Tocopherol promotes the reaction [APOB protein results in increased reduction of Copper] CTD PMID:11368321 (+)-catechin multiple interactions ISO RGD:735787 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of APOB mRNA CTD PMID:24763279 (+)-taxifolin decreases secretion ISO RGD:735787 6480464 taxifolin results in decreased secretion of APOB protein CTD PMID:15380446 (+)-taxifolin decreases expression ISO RGD:735787 6480464 taxifolin results in decreased expression of APOB protein CTD PMID:11108730 (-)-ephedrine multiple interactions ISO RGD:735787 6480464 [Ephedrine co-treated with Caffeine] results in decreased expression of APOB protein CTD PMID:16324916 1-naphthyl isothiocyanate multiple interactions ISO RGD:735787 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of APOB mRNA CTD PMID:27344345 13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE multiple interactions ISO RGD:735787 6480464 [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of APOB protein CTD PMID:15769986 17alpha-ethynylestradiol multiple interactions ISO RGD:735787 6480464 [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of APOB protein CTD PMID:15769986 17alpha-ethynylestradiol multiple interactions ISO RGD:735788 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of APOB mRNA CTD PMID:17942748 17beta-estradiol increases stability ISO RGD:735787 6480464 Estradiol results in increased stability of APOB protein CTD PMID:11076531 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:735788 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of APOB mRNA; more ... CTD PMID:17942748 PMID:21846477 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735788 6480464 Tetrachlorodibenzodioxin results in increased expression of APOB mRNA CTD PMID:22539624 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of APOB mRNA CTD PMID:20959002 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:735788 6480464 Tetrachlorodibenzodioxin results in decreased expression of APOB mRNA CTD PMID:21846477 PMID:28238261 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of APOB mRNA CTD PMID:11752688 PMID:15644576 2,4,6-trinitrobenzenesulfonic acid decreases expression ISO RGD:735788 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of APOB mRNA CTD PMID:17982090 2,4-dinitrotoluene affects expression EXP 6480464 2,4-dinitrotoluene affects the expression of APOB mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2,6-dinitrotoluene affects the expression of APOB mRNA CTD PMID:21346803 2-amino-2-deoxy-D-glucopyranose increases degradation EXP 6480464 Glucosamine results in increased degradation of APOB protein CTD PMID:15618547 2-amino-2-deoxy-D-glucopyranose increases ubiquitination ISO RGD:735787 6480464 Glucosamine results in increased ubiquitination of APOB protein CTD PMID:15618547 2-amino-2-deoxy-D-glucopyranose decreases secretion ISO RGD:735787 6480464 Glucosamine results in decreased secretion of APOB protein CTD PMID:15618547 2-amino-2-deoxy-D-glucopyranose decreases localization ISO RGD:735787 6480464 Glucosamine results in decreased localization of APOB protein CTD PMID:15618547 2-amino-2-deoxy-D-glucopyranose decreases expression ISO RGD:735787 6480464 Glucosamine results in decreased expression of APOB protein CTD PMID:15618547 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:735787 6480464 acetylleucyl-leucyl-norleucinal inhibits the reaction [Glucosamine results in decreased expression of and results in decreased secretion of APOB protein]; more ... CTD PMID:15618547 PMID:19383982 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 Oleic Acid inhibits the reaction [Glucosamine results in increased degradation of APOB protein] CTD PMID:15618547 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression EXP 6480464 Puromycin Aminonucleoside results in increased expression of APOB protein CTD PMID:2725289 more ... 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:735788 6480464 [3,4,5,3',4'-pentachlorobiphenyl co-treated with Methionine deficiency co-treated with Choline deficiency] results in decreased expression of APOB mRNA CTD PMID:28973532 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of APOB mRNA CTD PMID:28522335 acetic anhydride multiple interactions ISO RGD:735787 6480464 [Sodium Acetate co-treated with acetic anhydride] results in increased acetylation of APOB protein CTD PMID:11304478 acetylleucyl-leucyl-norleucinal multiple interactions ISO RGD:735787 6480464 acetylleucyl-leucyl-norleucinal inhibits the reaction [4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline results in decreased secretion of APOB protein]; more ... CTD PMID:19342510 PMID:19383982 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of APOB mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:735787 6480464 Aflatoxin B1 affects the expression of APOB protein CTD PMID:20106945 aldehydo-D-glucosamine increases degradation EXP 6480464 Glucosamine results in increased degradation of APOB protein CTD PMID:15618547 aldehydo-D-glucosamine increases ubiquitination ISO RGD:735787 6480464 Glucosamine results in increased ubiquitination of APOB protein CTD PMID:15618547 aldehydo-D-glucosamine decreases secretion ISO RGD:735787 6480464 Glucosamine results in decreased secretion of APOB protein CTD PMID:15618547 aldehydo-D-glucosamine decreases localization ISO RGD:735787 6480464 Glucosamine results in decreased localization of APOB protein CTD PMID:15618547 aldehydo-D-glucosamine decreases expression ISO RGD:735787 6480464 Glucosamine results in decreased expression of APOB protein CTD PMID:15618547 aldehydo-D-glucosamine multiple interactions ISO RGD:735787 6480464 acetylleucyl-leucyl-norleucinal inhibits the reaction [Glucosamine results in decreased expression of and results in decreased secretion of APOB protein]; more ... CTD PMID:15618547 PMID:19383982 aldehydo-D-glucosamine multiple interactions EXP 6480464 Oleic Acid inhibits the reaction [Glucosamine results in increased degradation of APOB protein] CTD PMID:15618547 aldehydo-D-glucose multiple interactions ISO RGD:735787 6480464 Glucose promotes the reaction [Copper Sulfate results in increased cleavage of APOB protein] CTD PMID:19489629 aluminium atom increases expression ISO RGD:735787 6480464 Aluminum results in increased expression of APOB protein CTD PMID:17762189 aluminium(0) increases expression ISO RGD:735787 6480464 Aluminum results in increased expression of APOB protein CTD PMID:17762189 aluminium(3+) increases expression ISO RGD:735787 6480464 Aluminum results in increased expression of APOB protein CTD PMID:17762189 amiodarone decreases expression ISO RGD:735787 6480464 Amiodarone results in decreased expression of APOB mRNA CTD PMID:29248575 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of APOB mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:735787 6480464 Antirheumatic Agents results in decreased expression of APOB mRNA CTD PMID:24449571 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of APOB mRNA CTD PMID:18178546 atenolol increases expression ISO RGD:735787 6480464 Atenolol results in increased expression of APOB; more ... CTD PMID:1928808 PMID:2193493 atorvastatin calcium multiple interactions EXP 6480464 Atorvastatin inhibits the reaction [Fructose results in increased expression of APOB protein] CTD PMID:12065722 atorvastatin calcium decreases secretion ISO RGD:735787 6480464 Atorvastatin results in decreased secretion of APOB protein CTD PMID:10357840 more ... atorvastatin calcium decreases expression ISO RGD:735787 6480464 Atorvastatin results in decreased expression of APOB protein CTD PMID:12172771 more ... atorvastatin calcium multiple interactions ISO RGD:735787 6480464 Atorvastatin results in decreased expression of and results in decreased secretion of APOB protein CTD PMID:12612140 benazepril multiple interactions ISO RGD:735787 6480464 [Valsartan co-treated with benazepril] results in decreased expression of APOB protein; more ... CTD PMID:20671225 bendroflumethiazide affects expression ISO RGD:735787 6480464 Bendroflumethiazide affects the expression of APOB protein CTD PMID:2344503 benzene increases expression EXP 6480464 Benzene results in increased expression of APOB mRNA CTD PMID:15878777 benzo[a]pyrene decreases expression ISO RGD:735787 6480464 Benzo(a)pyrene results in decreased expression of APOB mRNA CTD PMID:20106945 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:735787 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of APOB mRNA CTD PMID:26238291 Benzo[k]fluoranthene decreases expression ISO RGD:735788 6480464 benzo(k)fluoranthene results in decreased expression of APOB mRNA CTD PMID:26377693 beta-D-glucosamine increases degradation EXP 6480464 Glucosamine results in increased degradation of APOB protein CTD PMID:15618547 beta-D-glucosamine increases ubiquitination ISO RGD:735787 6480464 Glucosamine results in increased ubiquitination of APOB protein CTD PMID:15618547 beta-D-glucosamine decreases secretion ISO RGD:735787 6480464 Glucosamine results in decreased secretion of APOB protein CTD PMID:15618547 beta-D-glucosamine decreases localization ISO RGD:735787 6480464 Glucosamine results in decreased localization of APOB protein CTD PMID:15618547 beta-D-glucosamine decreases expression ISO RGD:735787 6480464 Glucosamine results in decreased expression of APOB protein CTD PMID:15618547 beta-D-glucosamine multiple interactions ISO RGD:735787 6480464 acetylleucyl-leucyl-norleucinal inhibits the reaction [Glucosamine results in decreased expression of and results in decreased secretion of APOB protein]; more ... CTD PMID:15618547 PMID:19383982 beta-D-glucosamine multiple interactions EXP 6480464 Oleic Acid inhibits the reaction [Glucosamine results in increased degradation of APOB protein] CTD PMID:15618547 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of APOB mRNA CTD PMID:16648578 bezafibrate multiple interactions ISO RGD:735787 6480464 Bezafibrate inhibits the reaction [Oleic Acid results in increased expression of APOB protein] CTD PMID:12048068 bezafibrate decreases expression ISO RGD:735787 6480464 Bezafibrate results in decreased expression of APOB protein CTD PMID:1323073 more ... bezafibrate increases expression EXP 6480464 Bezafibrate results in increased expression of APOB protein CTD PMID:9006809 bezafibrate multiple interactions EXP 6480464 [Bezafibrate co-treated with Ethanolamine] results in decreased secretion of APOB protein alternative form CTD PMID:8944747 bezafibrate decreases expression ISO RGD:735788 6480464 Bezafibrate results in decreased expression of APOB mRNA alternative form CTD PMID:12782154 bezafibrate decreases secretion ISO RGD:735787 6480464 Bezafibrate results in decreased secretion of APOB protein CTD PMID:21640707 bezafibrate multiple interactions ISO RGD:735788 6480464 PPARA protein affects the reaction [Bezafibrate results in decreased expression of APOB mRNA alternative form]; more ... CTD PMID:12782154 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of APOB mRNA CTD PMID:17010207 bisphenol A increases expression ISO RGD:735787 6480464 bisphenol A results in increased expression of APOB mRNA CTD PMID:28483554 bisphenol A increases expression ISO RGD:735788 6480464 bisphenol A results in increased expression of APOB mRNA CTD PMID:28483554 PMID:30245210 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of APOB mRNA CTD PMID:23399309 PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A results in decreased expression of APOB mRNA] which affects the abundance of Triglycerides; more ... CTD PMID:23399309 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of APOB mRNA CTD PMID:24136188 buta-1,3-diene decreases expression ISO RGD:735788 6480464 1,3-butadiene results in decreased expression of APOB mRNA CTD PMID:29038090 cadmium atom affects binding ISO RGD:735787 6480464 APOB protein binds to Cadmium CTD PMID:23896426 caffeine multiple interactions ISO RGD:735787 6480464 [Ephedrine co-treated with Caffeine] results in decreased expression of APOB protein CTD PMID:16324916 caffeine multiple interactions EXP 6480464 [Caffeine co-treated with Dietary Fats] results in increased expression of APOB mRNA CTD PMID:29800656 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of APOB mRNA CTD PMID:25868845 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of APOB mRNA CTD PMID:17293106 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of APOB mRNA CTD PMID:16278290 carbon nanotube increases expression ISO RGD:735788 6480464 Nanotubes, Carbon analog results in increased expression of APOB mRNA CTD PMID:25554681 catechin multiple interactions ISO RGD:735787 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of APOB mRNA CTD PMID:24763279 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of APOB mRNA CTD PMID:18500788 cholesterol increases expression EXP 6480464 Cholesterol results in increased expression of APOB protein CTD PMID:16271152 PMID:16581047 cholesterol multiple interactions EXP 6480464 Selenium inhibits the reaction [Cholesterol results in increased expression of APOB protein] CTD PMID:16581047 choline multiple interactions ISO RGD:735788 6480464 [3,4,5,3',4'-pentachlorobiphenyl co-treated with Methionine deficiency co-treated with Choline deficiency] results in decreased expression of APOB mRNA; more ... CTD PMID:25178843 PMID:28973532 choline increases expression ISO RGD:735788 6480464 Choline deficiency results in increased expression of APOB mRNA CTD PMID:25178843 chromium(6+) affects expression ISO RGD:735788 6480464 chromium hexavalent ion affects the expression of APOB mRNA CTD PMID:28472532 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of APOB protein CTD PMID:22023808 clofibrate decreases expression ISO RGD:735788 6480464 Clofibrate results in decreased expression of APOB protein CTD PMID:20573577 clofibric acid multiple interactions EXP 6480464 [Clofibric Acid co-treated with Ethanolamine] results in decreased secretion of APOB protein alternative form CTD PMID:8944747 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of APOB mRNA CTD PMID:24386269 copper atom multiple interactions ISO RGD:735787 6480464 alpha-Tocopherol promotes the reaction [APOB protein results in increased reduction of Copper]; more ... CTD PMID:11368321 PMID:17475462 copper atom affects binding ISO RGD:735787 6480464 APOB protein binds to Copper CTD PMID:23896426 copper atom increases reduction ISO RGD:735787 6480464 APOB protein results in increased reduction of Copper CTD PMID:11368321 copper atom multiple interactions EXP 6480464 [Fructose co-treated with Copper deficiency] results in decreased expression of APOB mRNA; more ... CTD PMID:25813056 copper atom increases oxidation ISO RGD:735787 6480464 Copper results in increased oxidation of APOB protein CTD PMID:17475462 copper(0) multiple interactions ISO RGD:735787 6480464 alpha-Tocopherol promotes the reaction [APOB protein results in increased reduction of Copper]; more ... CTD PMID:11368321 PMID:17475462 copper(0) affects binding ISO RGD:735787 6480464 APOB protein binds to Copper CTD PMID:23896426 copper(0) increases reduction ISO RGD:735787 6480464 APOB protein results in increased reduction of Copper CTD PMID:11368321 copper(0) multiple interactions EXP 6480464 [Fructose co-treated with Copper deficiency] results in decreased expression of APOB mRNA; more ... CTD PMID:25813056 copper(0) increases oxidation ISO RGD:735787 6480464 Copper results in increased oxidation of APOB protein CTD PMID:17475462 copper(2+) multiple interactions ISO RGD:735787 6480464 alpha-Tocopherol promotes the reaction [APOB protein results in increased reduction of Copper]; more ... CTD PMID:11368321 PMID:17475462 copper(2+) increases reduction ISO RGD:735787 6480464 APOB protein results in increased reduction of Copper CTD PMID:11368321 copper(2+) multiple interactions EXP 6480464 [Fructose co-treated with Copper deficiency] results in decreased expression of APOB mRNA; more ... CTD PMID:25813056 copper(2+) increases oxidation ISO RGD:735787 6480464 Copper results in increased oxidation of APOB protein CTD PMID:17475462 copper(2+) affects binding ISO RGD:735787 6480464 APOB protein binds to Copper CTD PMID:23896426 copper(II) sulfate decreases expression ISO RGD:735787 6480464 Copper Sulfate results in decreased expression of APOB mRNA CTD PMID:19549813 copper(II) sulfate increases cleavage ISO RGD:735787 6480464 Copper Sulfate results in increased cleavage of APOB protein CTD PMID:19489629 copper(II) sulfate multiple interactions ISO RGD:735787 6480464 Glucose promotes the reaction [Copper Sulfate results in increased cleavage of APOB protein] CTD PMID:19489629 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of APOB mRNA CTD PMID:18246545 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of APOB mRNA CTD PMID:19224547 cyclosporin A decreases expression ISO RGD:735787 6480464 Cyclosporine results in decreased expression of APOB mRNA CTD PMID:20106945 PMID:25562108 cyclosporin A decreases expression ISO RGD:735788 6480464 Cyclosporine results in decreased expression of APOB mRNA CTD PMID:19770486 cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of APOB mRNA CTD PMID:9650644 D-glucosamine increases degradation EXP 6480464 Glucosamine results in increased degradation of APOB protein CTD PMID:15618547 D-glucosamine decreases secretion ISO RGD:735787 6480464 Glucosamine results in decreased secretion of APOB protein CTD PMID:15618547 D-glucosamine multiple interactions ISO RGD:735787 6480464 acetylleucyl-leucyl-norleucinal inhibits the reaction [Glucosamine results in decreased expression of and results in decreased secretion of APOB protein]; more ... CTD PMID:15618547 PMID:19383982 D-glucosamine increases ubiquitination ISO RGD:735787 6480464 Glucosamine results in increased ubiquitination of APOB protein CTD PMID:15618547 D-glucosamine multiple interactions EXP 6480464 Oleic Acid inhibits the reaction [Glucosamine results in increased degradation of APOB protein] CTD PMID:15618547 D-glucosamine decreases localization ISO RGD:735787 6480464 Glucosamine results in decreased localization of APOB protein CTD PMID:15618547 D-glucosamine decreases expression ISO RGD:735787 6480464 Glucosamine results in decreased expression of APOB protein CTD PMID:15618547 D-glucose multiple interactions ISO RGD:735787 6480464 Glucose promotes the reaction [Copper Sulfate results in increased cleavage of APOB protein] CTD PMID:19489629 daunorubicin increases expression EXP 6480464 Daunorubicin results in increased expression of APOB protein CTD PMID:7637207 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of APOB protein CTD PMID:15965953 dicrotophos increases expression ISO RGD:735787 6480464 dicrotophos results in increased expression of APOB mRNA CTD PMID:28302478 diethyl phthalate increases degradation ISO RGD:735787 6480464 diethyl phthalate results in increased degradation of APOB protein CTD PMID:26423653 diethyl pyrocarbonate increases metabolic processing ISO RGD:735787 6480464 Diethyl Pyrocarbonate results in increased metabolism of APOB protein CTD PMID:11304478 dioxygen decreases expression ISO RGD:735788 6480464 Oxygen deficiency results in decreased expression of APOB mRNA CTD PMID:24205000 dorsomorphin multiple interactions ISO RGD:735787 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APOB mRNA CTD PMID:27188386 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of APOB protein CTD PMID:8255516 PMID:8506949 doxorubicin decreases expression ISO RGD:735787 6480464 Doxorubicin results in decreased expression of APOB mRNA CTD PMID:29803840 elemental selenium multiple interactions EXP 6480464 Selenium inhibits the reaction [Cholesterol results in increased expression of APOB protein] CTD PMID:16581047 elemental selenium decreases expression EXP 6480464 Selenium results in decreased expression of APOB protein CTD PMID:16271152 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of APOB mRNA CTD PMID:29391264 ethanol multiple interactions ISO RGD:735788 6480464 [Ethanol co-treated with Zinc] results in increased expression of APOB mRNA; more ... CTD PMID:19637192 PMID:24155903 ethanol multiple interactions EXP 6480464 Ethanol inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of APOB mRNA] CTD PMID:26854922 ethanol increases expression EXP 6480464 Ethanol results in increased expression of APOB mRNA CTD PMID:16946407 ethanolamine multiple interactions EXP 6480464 [3-deazaadenosine co-treated with Ethanolamine] results in decreased secretion of APOB protein alternative form; more ... CTD PMID:8944747 fenofibrate decreases expression ISO RGD:735787 6480464 Fenofibrate results in decreased expression of APOB protein CTD PMID:21411093 ferulic acid decreases expression ISO RGD:735788 6480464 ferulic acid results in decreased expression of APOB protein CTD PMID:20573577 flavonoids multiple interactions ISO RGD:735787 6480464 Ascorbic Acid promotes the reaction [Flavonoids inhibits the reaction [Copper results in increased oxidation of APOB protein]]; more ... CTD PMID:17475462 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of APOB mRNA CTD PMID:24793618 fluvastatin multiple interactions ISO RGD:735787 6480464 [APOB gene SNP co-treated with APOE gene SNP co-treated with HMGCR gene SNP co-treated with LDLR gene SNP co-treated with PCSK9 gene SNP co-treated with ABCA1 gene SNP co-treated with CETP gene SNP co-treated with LIPC gene SNP co-treated with LPL gene SNP] affects the susceptibility to fluvastatin; more ... CTD PMID:19773416 PMID:20671225 folic acid multiple interactions ISO RGD:735787 6480464 [Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of APOB protein CTD PMID:17237316 folic acid multiple interactions ISO RGD:735788 6480464 [APOE gene mutant form affects the susceptibility to Folic Acid] which results in decreased expression of APOB protein CTD PMID:17118406 folic acid increases expression ISO RGD:735787 6480464 Folic Acid results in increased expression of APOB mRNA CTD PMID:17868486 fructose multiple interactions EXP 6480464 [Fructose co-treated with Copper deficiency] results in decreased expression of APOB mRNA; more ... CTD PMID:12065722 PMID:25813056 fructose increases expression ISO RGD:735788 6480464 Fructose results in increased expression of APOB protein CTD PMID:27531227 fructose multiple interactions ISO RGD:735788 6480464 [FGF21 gene mutant form results in increased susceptibility to Fructose] which results in decreased expression of APOB mRNA; more ... CTD PMID:27531227 PMID:28123933 fructose increases expression EXP 6480464 Fructose results in increased expression of APOB mRNA; more ... CTD PMID:12065722 PMID:8415773 gadolinium trichloride multiple interactions EXP 6480464 gadolinium chloride promotes the reaction [[Fructose co-treated with Copper deficiency] results in decreased expression of APOB mRNA] CTD PMID:25813056 gallic acid decreases secretion ISO RGD:735787 6480464 Gallic Acid results in decreased secretion of APOB protein CTD PMID:12612140 gamma-hexachlorocyclohexane affects expression EXP 6480464 Hexachlorocyclohexane affects the expression of APOB mRNA CTD PMID:17785943 gemfibrozil decreases expression ISO RGD:735787 6480464 Gemfibrozil results in decreased expression of APOB protein CTD PMID:11701466 gemfibrozil decreases expression EXP 6480464 Gemfibrozil results in decreased expression of APOB protein CTD PMID:9006809 genistein increases expression EXP 6480464 Genistein results in increased expression of APOB mRNA; more ... CTD PMID:17010207 PMID:24552547 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of APOB mRNA CTD PMID:22061828 glucose multiple interactions ISO RGD:735787 6480464 Glucose promotes the reaction [Copper Sulfate results in increased cleavage of APOB protein] CTD PMID:19489629 graphite affects expression EXP 6480464 Graphite affects the expression of APOB mRNA CTD PMID:29933104 GW 4064 increases expression ISO RGD:735788 6480464 GW 4064 results in increased expression of APOB mRNA CTD PMID:26655953 hexadecanoic acid multiple interactions EXP 6480464 [Oleic Acid co-treated with Palmitic Acid] results in increased expression of APOB mRNA; more ... CTD PMID:26854922 hydrogen peroxide affects expression ISO RGD:735787 6480464 Hydrogen Peroxide affects the expression of APOB mRNA CTD PMID:20044591 irbesartan affects response to substance ISO RGD:735787 6480464 APOB gene SNP affects the susceptibility to irbesartan CTD PMID:15453913 PMID:15614026 L-ascorbic acid multiple interactions ISO RGD:735787 6480464 [Quercetin co-treated with Ascorbic Acid] results in decreased expression of APOB mRNA; more ... CTD PMID:17475462 PMID:17639512 L-methionine multiple interactions ISO RGD:735788 6480464 [3,4,5,3',4'-pentachlorobiphenyl co-treated with Methionine deficiency co-treated with Choline deficiency] results in decreased expression of APOB mRNA; more ... CTD PMID:25178843 PMID:28973532 lactacystin multiple interactions ISO RGD:735787 6480464 acetylleucyl-leucyl-norleucinal inhibits the reaction [lactacystin results in decreased expression of and results in decreased secretion of APOB protein]; more ... CTD PMID:15618547 PMID:19383982 lactacystin increases secretion ISO RGD:735787 6480464 lactacystin results in increased secretion of APOB protein CTD PMID:15618547 lactacystin increases expression ISO RGD:735787 6480464 lactacystin results in increased expression of APOB protein CTD PMID:15618547 levonorgestrel multiple interactions ISO RGD:735787 6480464 [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of APOB protein CTD PMID:15769986 linsidomine increases oxidation EXP 6480464 linsidomine results in increased oxidation of APOB protein CTD PMID:28086193 lovastatin multiple interactions ISO RGD:735787 6480464 [Niacin co-treated with Lovastatin] results in decreased expression of APOB protein CTD PMID:12633795 lovastatin decreases secretion ISO RGD:735787 6480464 Lovastatin results in decreased secretion of APOB protein CTD PMID:11728391 methylmercury chloride decreases expression ISO RGD:735787 6480464 methylmercuric chloride results in decreased expression of APOB mRNA CTD PMID:23179753 microcystin-LR affects expression ISO RGD:735788 6480464 cyanoginosin LR affects the expression of APOB protein CTD PMID:26984711 morphine increases expression ISO RGD:735787 6480464 Morphine results in increased expression of APOB protein CTD PMID:18980684 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression ISO RGD:735787 6480464 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of APOB protein CTD PMID:19637192 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO RGD:735787 6480464 Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of APOB protein] CTD PMID:19637192 Nandrolone decanoate increases expression ISO RGD:735787 6480464 nandrolone decanoate results in increased expression of APOB protein CTD PMID:16153628 nickel atom affects binding ISO RGD:735787 6480464 APOB protein binds to Nickel CTD PMID:23896426 nicotinic acid decreases expression ISO RGD:735787 6480464 Niacin results in decreased expression of APOB protein CTD PMID:11701466 PMID:15539964 nicotinic acid multiple interactions ISO RGD:735787 6480464 [Niacin co-treated with Lovastatin] results in decreased expression of APOB protein; more ... CTD PMID:12633795 PMID:18471454 Nonylphenol increases expression EXP 6480464 nonylphenol results in increased expression of APOB mRNA CTD PMID:17010207 obeticholic acid increases expression ISO RGD:735787 6480464 obeticholic acid results in increased expression of APOB mRNA CTD PMID:27939613 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of APOB mRNA CTD PMID:16251485 PMID:19717638 olanzapine increases phosphorylation ISO RGD:735787 6480464 olanzapine results in increased phosphorylation of APOB protein CTD PMID:25821032 oleic acid multiple interactions ISO RGD:735787 6480464 [Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of APOB protein; more ... CTD PMID:12048068 more ... oleic acid increases expression ISO RGD:735787 6480464 Oleic Acid results in increased expression of APOB protein CTD PMID:12048068 oleic acid multiple interactions EXP 6480464 [Oleic Acid co-treated with Palmitic Acid] results in increased expression of APOB mRNA; more ... CTD PMID:15618547 PMID:26854922 palmitoyl ethanolamide affects folding ISO RGD:735787 6480464 palmidrol affects the folding of APOB protein CTD PMID:16115474 paracetamol decreases expression ISO RGD:735787 6480464 Acetaminophen results in decreased expression of APOB mRNA CTD PMID:21420995 more ... perfluorooctane-1-sulfonic acid decreases expression ISO RGD:735788 6480464 perfluorooctane sulfonic acid results in decreased expression of APOB mRNA CTD PMID:21705711 perfluorooctanoic acid affects localization EXP 6480464 perfluorooctanoic acid affects the localization of APOB protein CTD PMID:10101272 perfluorooctanoic acid decreases expression ISO RGD:735787 6480464 perfluorooctanoic acid results in decreased expression of APOB protein CTD PMID:26879310 phenobarbital decreases expression ISO RGD:735788 6480464 Phenobarbital results in decreased expression of APOB mRNA CTD PMID:23091169 phenylmercury acetate multiple interactions ISO RGD:735787 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APOB mRNA CTD PMID:27188386 pioglitazone decreases expression ISO RGD:735787 6480464 pioglitazone results in decreased expression of APOB protein CTD PMID:16324916 pirinixic acid decreases expression ISO RGD:735788 6480464 pirinixic acid results in decreased expression of APOB protein CTD PMID:15537571 pirinixic acid increases secretion ISO RGD:735788 6480464 pirinixic acid results in increased secretion of APOB protein CTD PMID:16282640 pirinixic acid increases secretion EXP 6480464 pirinixic acid results in increased secretion of APOB protein alternative form CTD PMID:15537571 potassium dichromate affects expression ISO RGD:735788 6480464 Potassium Dichromate affects the expression of APOB mRNA CTD PMID:23608068 Propiverine affects binding EXP 6480464 propiverine binds to APOB protein CTD PMID:29273565 quercetin increases expression EXP 6480464 Quercetin results in increased expression of APOB mRNA CTD PMID:21565894 quercetin decreases expression ISO RGD:735787 6480464 Quercetin results in decreased expression of APOB mRNA; more ... CTD PMID:21632981 PMID:25875015 quercetin multiple interactions ISO RGD:735787 6480464 [Quercetin co-treated with Ascorbic Acid] results in decreased expression of APOB mRNA; more ... CTD PMID:17475462 more ... quercetin decreases secretion ISO RGD:735787 6480464 Quercetin results in decreased secretion of APOB protein CTD PMID:12612140 resveratrol decreases secretion ISO RGD:735787 6480464 resveratrol results in decreased secretion of APOB protein CTD PMID:12612140 resveratrol decreases expression ISO RGD:735788 6480464 resveratrol results in decreased expression of APOB protein CTD PMID:25505154 rosuvastatin calcium decreases expression ISO RGD:735787 6480464 Rosuvastatin Calcium results in decreased expression of APOB protein CTD PMID:15539964 PMID:18702965 SB 431542 multiple interactions ISO RGD:735787 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APOB mRNA CTD PMID:27188386 selenium atom multiple interactions EXP 6480464 Selenium inhibits the reaction [Cholesterol results in increased expression of APOB protein] CTD PMID:16581047 selenium atom decreases expression EXP 6480464 Selenium results in decreased expression of APOB protein CTD PMID:16271152 simvastatin multiple interactions ISO RGD:735787 6480464 [LDLR 3' UTR polymorphism affects the susceptibility to Simvastatin] which affects the expression of APOB; more ... CTD PMID:18471454 PMID:20413733 simvastatin decreases secretion ISO RGD:735787 6480464 Simvastatin results in decreased secretion of APOB protein CTD PMID:11728391 more ... simvastatin decreases expression ISO RGD:735787 6480464 Simvastatin results in decreased expression of APOB protein CTD PMID:10498134 more ... simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of APOB mRNA; more ... CTD PMID:8289597 PMID:8461338 simvastatin multiple interactions EXP 6480464 Simvastatin promotes the reaction [Polystyrenes analog results in decreased expression of APOB protein] CTD PMID:8461338 simvastatin affects response to substance ISO RGD:735787 6480464 APOB polymorphism affects the susceptibility to Simvastatin CTD PMID:12901521 sodium acetate trihydrate multiple interactions ISO RGD:735787 6480464 [Sodium Acetate co-treated with acetic anhydride] results in increased acetylation of APOB protein CTD PMID:11304478 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of APOB mRNA CTD PMID:22110744 sodium fluoride increases expression ISO RGD:735788 6480464 Sodium Fluoride results in increased expression of APOB mRNA CTD PMID:27862939 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of APOB mRNA CTD PMID:19224547 tetrachloromethane decreases expression ISO RGD:735788 6480464 Carbon Tetrachloride results in decreased expression of APOB protein CTD PMID:17405876 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of APOB mRNA CTD PMID:16644059 PMID:19224547 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of APOB mRNA CTD PMID:15963342 tetracycline decreases expression EXP 6480464 Tetracycline results in decreased expression of APOB mRNA CTD PMID:19224547 thioacetamide multiple interactions ISO RGD:735788 6480464 Thioacetamide inhibits the reaction [SOD1 gene mutant form results in decreased expression of APOB protein] CTD PMID:27349771 tolcapone decreases expression ISO RGD:735787 6480464 tolcapone results in decreased expression of APOB mRNA CTD PMID:29688484 tolcapone decreases secretion ISO RGD:735787 6480464 tolcapone results in decreased secretion of APOB protein alternative form CTD PMID:29688484 trichloroethene decreases expression ISO RGD:735788 6480464 Trichloroethylene results in decreased expression of APOB mRNA CTD PMID:19448997 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of APOB mRNA CTD PMID:24136188 valproic acid decreases methylation ISO RGD:735787 6480464 Valproic Acid results in decreased methylation of APOB gene CTD PMID:29154799 valproic acid increases expression ISO RGD:735787 6480464 Valproic Acid results in increased expression of APOB mRNA; more ... CTD PMID:25716160 PMID:29501571 valproic acid decreases expression ISO RGD:735787 6480464 Valproic Acid results in decreased expression of APOB mRNA CTD PMID:23179753 more ... valsartan multiple interactions ISO RGD:735787 6480464 [Valsartan co-treated with benazepril] results in decreased expression of APOB protein; more ... CTD PMID:20671225 vitamin E multiple interactions ISO RGD:735787 6480464 [Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of APOB protein; more ... CTD PMID:11368321 more ... vorinostat decreases expression ISO RGD:735787 6480464 vorinostat results in decreased expression of APOB mRNA CTD PMID:27188386 wortmannin multiple interactions EXP 6480464 wortmannin inhibits the reaction [[bisphenol A results in decreased expression of APOB mRNA] which results in decreased abundance of Triglycerides]; more ... CTD PMID:23399309 zinc atom multiple interactions ISO RGD:735787 6480464 Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of APOB protein] CTD PMID:19637192 zinc atom affects binding ISO RGD:735787 6480464 APOB protein binds to Zinc CTD PMID:23896426 zinc atom affects expression ISO RGD:735788 6480464 Zinc deficiency affects the expression of APOB mRNA CTD PMID:24155903 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of APOB protein modified form CTD PMID:10498758 zinc atom multiple interactions ISO RGD:735788 6480464 [Ethanol co-treated with Zinc] results in increased expression of APOB mRNA; more ... CTD PMID:19637192 PMID:24155903 zinc atom affects expression EXP 6480464 Zinc deficiency affects the expression of APOB mRNA modified form CTD PMID:10498758 zinc(0) affects expression EXP 6480464 Zinc deficiency affects the expression of APOB mRNA modified form CTD PMID:10498758 zinc(0) multiple interactions ISO RGD:735788 6480464 [Ethanol co-treated with Zinc] results in increased expression of APOB mRNA; more ... CTD PMID:19637192 PMID:24155903 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of APOB protein modified form CTD PMID:10498758 zinc(0) multiple interactions ISO RGD:735787 6480464 Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of APOB protein] CTD PMID:19637192 zinc(0) affects expression ISO RGD:735788 6480464 Zinc deficiency affects the expression of APOB mRNA CTD PMID:24155903 zinc(0) affects binding ISO RGD:735787 6480464 APOB protein binds to Zinc CTD PMID:23896426
Biological Process artery morphogenesis ISO RGD:735788 1624291 MGI:MGI:88057 RGD MGI:MGI:3695082 PMID:16230502 artery morphogenesis IEA UniProtKB:E9Q414|ensembl:ENSMUSP00000036044 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cellular response to prostaglandin stimulus IEP 2325771 RGD cellular response to tumor necrosis factor IEP 2325768 RGD cholesterol efflux ISO RGD:735788 1624291 MGI:MGI:104539 RGD MGI:MGI:5428098 PMID:22363685 cholesterol efflux IEA UniProtKB:E9Q414|ensembl:ENSMUSP00000036044 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cholesterol homeostasis ISO RGD:735787 1624291 RGD PMID:2563166 cholesterol homeostasis IEA UniProtKB:P04114|ensembl:ENSP00000233242 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cholesterol homeostasis IEA UniProtKB:E9Q414|ensembl:ENSMUSP00000036044 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cholesterol homeostasis ISO RGD:735788 1624291 MGI:MGI:1857303|MGI:MGI:1857304|MGI:MGI:1857625|MGI:MGI:2157108|MGI:MGI:3665449|MGI:MGI:88057|MGI:MGI:96765 RGD MGI:MGI:1201298 more ... cholesterol metabolic process ISO RGD:735787 1624291 RGD PMID:2563166 cholesterol metabolic process IEA UniProtKB:P04114|ensembl:ENSP00000233242 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cholesterol transport ISO RGD:735788 1624291 MGI:MGI:2157090 RGD MGI:MGI:77225 PMID:7593600 cholesterol transport ISO RGD:735787 1624291 RGD PMID:2563166 fertilization ISO RGD:735788 1624291 MGI:MGI:2157090 RGD MGI:MGI:83280 PMID:8855280 fertilization IEA UniProtKB:E9Q414|ensembl:ENSMUSP00000036044 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 flagellated sperm motility ISO RGD:735788 1624291 MGI:MGI:2157090 RGD MGI:MGI:83280 PMID:8855280 flagellated sperm motility IEA UniProtKB:E9Q414|ensembl:ENSMUSP00000036044 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 in utero embryonic development ISO RGD:735788 1624291 MGI:MGI:1857625|MGI:MGI:2157775 RGD MGI:MGI:1201298 more ... in utero embryonic development IEA UniProtKB:E9Q414|ensembl:ENSMUSP00000036044 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 lipid catabolic process ISO RGD:735788 1624291 MGI:MGI:2183298 RGD MGI:MGI:3652707 PMID:16455790 lipid metabolic process ISO RGD:735788 1624291 MGI:MGI:1857141|MGI:MGI:2183298|MGI:MGI:88057|MGI:MGI:96765 RGD MGI:MGI:1928445 more ... lipid metabolic process IDA 1626403 RGD lipid transport IEA InterPro:IPR001747|InterPro:IPR009454|InterPro:IPR015255|InterPro:IPR015816|InterPro:IPR015819 1600115 GO_REF:0000002 InterPro GO_REF:0000002 lipoprotein biosynthetic process ISO RGD:735788 1624291 MGI:MGI:103298 RGD MGI:MGI:3028770 PMID:13130124 lipoprotein biosynthetic process IEA UniProtKB:E9Q414|ensembl:ENSMUSP00000036044 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 lipoprotein catabolic process ISO RGD:735788 1624291 MGI:MGI:107202 RGD MGI:MGI:3588634 PMID:15863839 lipoprotein catabolic process IEA UniProtKB:E9Q414|ensembl:ENSMUSP00000036044 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 lipoprotein metabolic process ISO RGD:735788 1624291 MGI:MGI:1857303|MGI:MGI:1857625|MGI:MGI:2157108|MGI:MGI:3665449|MGI:MGI:88057|MGI:MGI:96765 RGD MGI:MGI:1316893 more ... lipoprotein transport ISO RGD:735788 1624291 MGI:MGI:103298|MGI:MGI:2183298 RGD MGI:MGI:3028770 PMID:13130124 lipoprotein transport IEA UniProtKB:E9Q414|ensembl:ENSMUSP00000036044 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 low-density lipoprotein particle clearance ISO RGD:735787 1624291 RGD PMID:15797858 PMID:2563166 low-density lipoprotein particle clearance IEA UniProtKB:P04114|ensembl:ENSP00000233242 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 low-density lipoprotein particle remodeling ISO RGD:735787 1624291 RGD PMID:15797858 low-density lipoprotein particle remodeling IEA UniProtKB:P04114|ensembl:ENSP00000233242 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 nervous system development ISO RGD:735788 1624291 MGI:MGI:1857625|MGI:MGI:2157775|MGI:MGI:3665449 RGD MGI:MGI:1201298 more ... nervous system development IEA UniProtKB:E9Q414|ensembl:ENSMUSP00000036044 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of cholesterol storage ISO RGD:735787 1624291 RGD PMID:19114110 positive regulation of cholesterol storage IEA UniProtKB:P04114|ensembl:ENSP00000233242 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of gene expression ISO RGD:735788 1624291 RGD MGI:MGI:5520153 PMID:22897442 positive regulation of gene expression IEA UniProtKB:E9Q414|ensembl:ENSMUSP00000036044 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of lipid storage ISO RGD:735787 1624291 RGD PMID:18322245 positive regulation of macrophage derived foam cell differentiation ISO RGD:735787 1624291 RGD PMID:17244792 more ... positive regulation of macrophage derived foam cell differentiation IEA UniProtKB:P04114|ensembl:ENSP00000233242 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 post-embryonic development ISO RGD:735788 1624291 MGI:MGI:2157108 RGD MGI:MGI:1316893 PMID:9852051 post-embryonic development IEA UniProtKB:E9Q414|ensembl:ENSMUSP00000036044 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of cholesterol biosynthetic process ISO RGD:735788 1624291 MGI:MGI:2183298 RGD MGI:MGI:3652707 PMID:16455790 regulation of cholesterol biosynthetic process IEA UniProtKB:E9Q414|ensembl:ENSMUSP00000036044 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to carbohydrate IDA 1599166 RGD response to estradiol IEP 11353967 RGD response to lipopolysaccharide IEP 1599165 RGD response to organic substance IEP 1599170 RGD response to organic substance IEP 2325770 orotic acid RGD response to organic substance IEP 2325765 berberine RGD response to selenium ion IEP 1599167 RGD response to virus ISO RGD:735787 1624291 RGD PMID:16548883 response to virus IEA UniProtKB:P04114|ensembl:ENSP00000233242 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 spermatogenesis ISO RGD:735788 1624291 MGI:MGI:2157090 RGD MGI:MGI:83280 PMID:8855280 spermatogenesis IEA UniProtKB:E9Q414|ensembl:ENSMUSP00000036044 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 triglyceride catabolic process IMP 1626404 RGD triglyceride catabolic process ISO RGD:735788 1624291 MGI:MGI:2183298 RGD MGI:MGI:3652707 PMID:16455790 triglyceride mobilization ISO RGD:735788 1624291 MGI:MGI:2183298 RGD MGI:MGI:1913181 PMID:10893242 triglyceride mobilization IEA UniProtKB:E9Q414|ensembl:ENSMUSP00000036044 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 Cellular Component chylomicron ISO RGD:735787 1624291 RGD PMID:4363408 PMID:8245722 cytoplasm ISO RGD:735787 1624291 RGD PMID:22580899 cytoplasm ISS UniProtKB:P04114 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cytosol IEA UniProtKB:P04114|ensembl:ENSP00000233242 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cytosol ISO RGD:735787 1624291 RGD GO_REF:0000052 endoplasmic reticulum ISO RGD:735788 1624291 RGD MGI:MGI:2386141 PMID:12072432 endoplasmic reticulum exit site ISO RGD:735787 1624291 RGD PMID:27138255 endoplasmic reticulum exit site IEA UniProtKB:P04114|ensembl:ENSP00000233242 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 extracellular space IDA 1599170 RGD high-density lipoprotein particle IDA 1626402 RGD intermediate-density lipoprotein particle ISO RGD:735787 1624291 RGD PMID:1917954 intermediate-density lipoprotein particle IEA UniProtKB:P04114|ensembl:ENSP00000233242 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 intracellular membrane-bounded organelle IDA 1626402 RGD intracellular membrane-bounded organelle ISO RGD:735787 1624291 RGD GO_REF:0000052 low-density lipoprotein particle ISO RGD:735787 1624291 RGD PMID:4363408 low-density lipoprotein particle IDA 11353963 RGD mature chylomicron ISO RGD:735787 1624291 RGD PMID:4363408 mature chylomicron IEA UniProtKB:P04114|ensembl:ENSP00000233242 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 neuronal cell body ISO RGD:735787 1624291 RGD PMID:22897442 neuronal cell body IEA UniProtKB:P04114|ensembl:ENSP00000233242 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 very-low-density lipoprotein particle IDA 2325767 RGD very-low-density lipoprotein particle IDA 1626402 RGD very-low-density lipoprotein particle ISO RGD:735787 1624291 RGD PMID:15308631 PMID:4363408 vesicle lumen IDA 1626402 RGD vesicle membrane IDA 1626402 RGD Molecular Function cholesterol transporter activity ISO RGD:735787 1624291 RGD PMID:15797858 cholesterol transporter activity IEA UniProtKB:P04114|ensembl:ENSP00000233242 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 heparin binding ISO RGD:735787 1624291 RGD PMID:16233946 heparin binding IEA UniProtKB:P04114|ensembl:ENSP00000233242 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 lipase binding ISO RGD:735787 1624291 UniProtKB:P07867 RGD PMID:9685400 lipase binding IEA UniProtKB:P04114|ensembl:ENSP00000233242 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 lipid transporter activity IEA InterPro:IPR001747|InterPro:IPR009454|InterPro:IPR015255|InterPro:IPR015816|InterPro:IPR015819 1600115 GO_REF:0000002 InterPro GO_REF:0000002 low-density lipoprotein particle receptor binding ISO RGD:735787 1624291 RGD PMID:15797858 PMID:2563166 low-density lipoprotein particle receptor binding IEA UniProtKB:P04114|ensembl:ENSP00000233242 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 phospholipid binding ISO RGD:735787 1624291 RGD PMID:7126555 phospholipid binding IEA UniProtKB:P04114|ensembl:ENSP00000233242 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein binding IPI RGD:1308388 1582567 RGD protein binding IPI UniProtKB:P04639 13432334 PMID:18391222 IntAct protein binding ISO RGD:735787 1624291 UniProtKB:O15320|UniProtKB:P01130|UniProtKB:P02652|UniProtKB:P27958:PRO_0000037576|UniProtKB:P29991:PRO_0000037946|UniProtKB:P55157|UniProtKB:Q5JRA6|UniProtKB:Q8NBP7 RGD PMID:16203724 more ...
Gene-Chemical Interaction Annotations
